Sentence: In 2011 , the combination of rituximab with bendamustine ( 31 % ) was most frequent used followed by the rituximab-fludarabine-cyclophosphamide ( 22 % ) regime .
Drug combination annotation:
[{'class': 'POS', 'spans': ['rituximab', 'bendamustine'], 'is_context_needed': True}]